Oragenics (OGEN) Assets Average (2011 - 2026)

Oragenics (OGEN) has 16 years of Assets Average data on file, last reported at $8.8 million in Q1 2026.

• Quarterly Assets Average rose 228.69% year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (up 228.69% YoY) and the FY2025 annual result came in at $5.8 million, up 79.23% from the prior year.
• Assets Average retreated to $8.8 million in Q1 2026, from $11.4 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $25.9 million in Q1 2022 to a low of $2.7 million in Q1 2025.
• A 5-year average of $9.9 million and a median of $8.2 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2024 — Assets Average tumbled 69.68% — and 2025, when it surged 241.09%.
• Tracing OGEN's Assets Average over 5 years: stood at $15.9 million in 2022, then plunged by 59.55% to $6.4 million in 2023, then tumbled by 48.11% to $3.3 million in 2024, then surged by 241.09% to $11.4 million in 2025, then decreased by 22.9% to $8.8 million in 2026.
• The last three Assets Average figures came in at $8.8 million (Q1 2026), $11.4 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.